ChemoCentryx: 2Q Earnings Snapshot
MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Monday reported a loss of $15.2 million in its second quarter.
On a per-share basis, the Mountain View, California-based company said it had a loss of 26 cents.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.
The biopharmaceutical company posted revenue of $7.2 million in the period, also missing Street forecasts. Six analysts surveyed by Zacks expected $10.1 million.
ChemoCentryx shares have decreased 30% since the beginning of the year. In the final minutes of trading on Monday, shares hit $7.62, a fall of 31% in the last 12 months.